Catalyst Event
Jiangsu Hengrui Pharmaceuticals Co Ltd (1276) · Other
From Akros SCHK HK-U.S. Tech 100 Index (ASHUSTC)
5/12/2026, 12:00:00 AM
Global strategic collaboration and licensing agreement with Bristol-Myers Squibb (BMS) for 13 early-stage programs in oncology, hematology, and immunology, with a potential value of up to $15.2 billion and upfront/near-term payments of $950 million; the high deal value is estimated to result in a price impact exceeding 10%, scheduled
Korean Translation
브리스톨 마이어스 스퀴브(BMS)와 종양학, 혈액학, 면역학 분야 13개 초기 단계 프로그램에 대한 글로벌 전략적 협력 및 라이선스 계약 체결을 발표할 예정임. 총 계약 규모는 최대 152억 달러, 선급금 및 단기 마일스톤은 9억 5천만 달러에 달하며 대규모 계약 특성상 10% 이상의 주가 영향이 예상됨
Related Recent Events
3SBio Inc (1530) · Earnings Release
First half 2026 earnings results are expected to be released around August 26, 2026, expected. High importance is estimated due to the significant impact of previous earnings growth on stock volatility.
8/26/2026, 12:00:00 AM
Microsoft Corp (MSFT) · Earnings Release
Microsoft is scheduled to report its Q4 and full-year fiscal 2026 earnings results on 2026-07-28, with analysts forecasting EPS around $4.24-$4.33. High importance is estimated due to typical 10% price volatility following earnings scheduled.
7/28/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Other
AMD's 'Advancing AI 2026' event to detail future AI product roadmaps on July 23, 2026 is expected to have a 5% price impact scheduled.
7/23/2026, 12:00:00 AM
Amphenol Corp (APH) · Earnings Release
Next quarterly earnings release for Q2 2026 is a routine administrative event with low expected impact, scheduled.
7/22/2026, 12:00:00 AM
Thermo Fisher Scientific Inc (TMO) · Earnings Release
Q2 2026 earnings release scheduled for 2026-07-22; low importance estimated as earnings typically cause moderate volatility, expected.
7/22/2026, 12:00:00 AM
3SBio Inc (1530) · Other
The ex-dividend date for the final cash dividend of HKD 0.25 per share for the fiscal year 2025 is July 21, 2026, scheduled.
7/21/2026, 12:00:00 AM